Dr. James D. Battiste
Claim this profileUniversity of Oklahoma Health Sciences Center
Area of expertise
Brain Tumor
James D. Battiste has run 7 trials for Brain Tumor. Some of their research focus areas include:
Glioblastoma
James D. Battiste has run 7 trials for Glioblastoma. Some of their research focus areas include:
Affiliated Hospitals
University Of Oklahoma Health Sciences Center
Cancer Centers Of Southwest Oklahoma Research
Clinical Trials James D. Battiste is currently running
Multiple Targeted Therapies
for Meningioma
This trial studies four drugs to treat patients with worsening meningioma. These drugs work by blocking enzymes that the tumor cells need to grow. The trial focuses on patients whose tumors have specific genetic mutations.
Recruiting
1 award
Phase 2
10 criteria
Relatlimab + Nivolumab
for Recurrent Glioblastoma
This phase II trial compares the safety, side effects and effectiveness of anti-lag-3 (relatlimab) and anti-PD-1 blockade (nivolumab) to standard of care lomustine for the treatment of patients with glioblastoma that has come back after a period of improvement (recurrent). Relatlimab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the tumor, and may interfere with the ability of tumor cells to grow and spread. Lomustine is a chemotherapy drug and in a class of medications called alkylating agents. It damages the cell's deoxyribonucleic acid and may kill tumor cells. Giving relatlimab and nivolumab may be safe, tolerable, and/or effective compared to standard of care lomustine in treating patients with recurrent glioblastoma.
Recruiting
1 award
Phase 2
15 criteria
More about James D. Battiste
Clinical Trial Related
1 year of experience running clinical trials · Led 12 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments James D. Battiste has experience with
- Nivolumab
- Abemaciclib
- Temozolomide
- Radiation Therapy
- Ipilimumab
- DCVax®-L
Breakdown of trials James D. Battiste has run
Brain Tumor
Glioblastoma
Brain Cancer
Protoplasmic Astrocytoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does James D. Battiste specialize in?
James D. Battiste focuses on Brain Tumor and Glioblastoma. In particular, much of their work with Brain Tumor has involved Stage IV patients, or patients who are SMO positive.
Is James D. Battiste currently recruiting for clinical trials?
Yes, James D. Battiste is currently recruiting for 3 clinical trials in Oklahoma City Oklahoma. If you're interested in participating, you should apply.
Are there any treatments that James D. Battiste has studied deeply?
Yes, James D. Battiste has studied treatments such as Nivolumab, Abemaciclib, Temozolomide.
What is the best way to schedule an appointment with James D. Battiste?
Apply for one of the trials that James D. Battiste is conducting.
What is the office address of James D. Battiste?
The office of James D. Battiste is located at: University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104 United States. This is the address for their practice at the University of Oklahoma Health Sciences Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.